Terms: = Bone cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Prognosis
14 results:
1. Clinicopathological Features and prognosis of Lung Adenocarcinoma Patients With k-ras Gene Mutation.
Sun D; Liu Y; Li P; Yang P; Yu G
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):406-413. PubMed ID: 37338109
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a novel subpopulation of Caspase-4 positive non-small cell lung cancer patients.
Terlizzi M; Colarusso C; De Rosa I; Somma P; Curcio C; Aquino RP; Panico L; Salvi R; Zito Marino F; Botti G; Pinto A; Sorrentino R
J Exp Clin Cancer Res; 2020 Nov; 39(1):242. PubMed ID: 33187551
[TBL] [Abstract] [Full Text] [Related]
3. Shared and Tissue-Specific Expression Signatures between bone Marrow from Primary Myelofibrosis and Essential Thrombocythemia.
Ishikawa G; Fujiwara N; Hirschfield H; Varricchio L; Hoshida Y; Barosi G; Rosti V; Padilla M; Mazzarini M; Friedman SL; Hoffman R; Migliaccio AR
Exp Hematol; 2019 Nov; 79():16-25.e3. PubMed ID: 31678370
[TBL] [Abstract] [Full Text] [Related]
4. SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway.
Zhou S; Liang Y; Zhang X; Liao L; Yang Y; Ouyang W; Xu H
J Invest Dermatol; 2020 Feb; 140(2):395-403.e6. PubMed ID: 31401046
[TBL] [Abstract] [Full Text] [Related]
5. The Mutational Profile of Unicystic Ameloblastoma.
Heikinheimo K; Huhtala JM; Thiel A; Kurppa KJ; Heikinheimo H; Kovac M; Kragelund C; Warfvinge G; Dawson H; Elenius K; Ristimäki A; Baumhoer D; Morgan PR
J Dent Res; 2019 Jan; 98(1):54-60. PubMed ID: 30216733
[TBL] [Abstract] [Full Text] [Related]
6. Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma.
Chang DZ; Ma Y; Ji B; Wang H; Deng D; Liu Y; Abbruzzese JL; Liu YJ; Logsdon CD; Hwu P
Clin Cancer Res; 2011 Nov; 17(22):7015-23. PubMed ID: 21976550
[TBL] [Abstract] [Full Text] [Related]
7. Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma.
Bisping G; Wenning D; Kropff M; Gustavus D; Müller-Tidow C; Stelljes M; Munzert G; Hilberg F; Roth GJ; Stefanic M; Volpert S; Mesters RM; Berdel WE; Kienast J
Clin Cancer Res; 2009 Jan; 15(2):520-31. PubMed ID: 19147757
[TBL] [Abstract] [Full Text] [Related]
8. High-dose chemotherapy for male germ cell tumor.
Hara I; Miyake H; Yamada Y; Takenaka A; Fujisawa M
Int J Urol; 2006 Aug; 13(8):1037-44. PubMed ID: 16903926
[TBL] [Abstract] [Full Text] [Related]
9. [Point mutations of n-ras oncogene and abnormal expression of rasp21, p53 proteins in orbital rhabdomyosarcoma].
Zhang H; Song G; Zhang S; Chang J; Zhang W; Yu H
Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):267-9, 16. PubMed ID: 11853610
[TBL] [Abstract] [Full Text] [Related]
10. Molecular biological markers and micrometastasis in resected non-small-cell lung cancer. Prognostic implications.
Osaki T; Oyama T; Inoue M; Gu CD; Kodate M; Aikawa M; So T; Mizukami M; Mitsudomi T; Yasumoto K
Jpn J Thorac Cardiovasc Surg; 2001 Sep; 49(9):545-51. PubMed ID: 11577444
[TBL] [Abstract] [Full Text] [Related]
11. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
[TBL] [Abstract] [Full Text] [Related]
12. p53 tumor suppressor protein and H-RAS oncogene in maxillofacial tumors: immunohistochemical and genetic investigation, induction chemotherapy response and prognosis evaluation.
Cutilli T; Papola F; Di Emidio P; Corbacelli A
J Chemother; 1998 Oct; 10(5):411-7. PubMed ID: 9822361
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathologic implications of MDM2, p53 and k-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors.
Yokoyama R; Schneider-Stock R; Radig K; Wex T; Roessner A
Pathol Res Pract; 1998; 194(9):615-21. PubMed ID: 9793960
[TBL] [Abstract] [Full Text] [Related]
14. The proliferation of multiple myeloma colonies (MY-CFUc) in vitro is independent of prognosis and is not associated with mutated N- or k-ras alleles in human bone marrow aspirates.
Millar BC; Bell JB; Barfoot R; Everard M
Br J Cancer; 1995 Feb; 71(2):259-64. PubMed ID: 7841038
[TBL] [Abstract] [Full Text] [Related]